Torys LLP acted as counsel to Triumvira Immunologics on the collaboration with Merck. On January 5, 2023, Triumvira Immunologics, Inc. (“Triumvira”) announced a clinical trial collaboration...
You must be a Standard 1 Year member to access this content.
Torys LLP acted as counsel to QV Global Health Sciences Fund. Alpha-9 Theranostics Inc. announced an oversubscribed US$75 million Series B financing to advance its portfolio of...
You must be a Standard 1 Year member to access this content.
Torys LLP acted as strategic advisor to the Government of Canada on the agreement. On April 29, 2022, The Canadian Prime Minister, Justin Trudeau, announced that...
You must be a Standard 1 Year member to access this content.
Latham & Watkins, Torys LLP and Goodwin represented Triumvira Immunologics in the transaction. Triumvira Immunologics, a clinical-stage company developing novel, targeted autologous and allogeneic T cell...
You must be a Standard 1 Year member to access this content.
Torys LLP acted for Entos Pharmaceuticals. On January 6, 2022, Eli Lilly and Company (NYSE:LLY) acquired exclusive rights to Entos’ Fusogenix nucleic acid delivery technology to research,...
You must be a Standard 1 Year member to access this content.
Torys LLP acted as counsel to Conavi Medical in connection with the financing. On December 15, 2021, Conavi Medical Inc. entered into agreements for over US$20...
You must be a Standard 1 Year member to access this content.
Torys LLP acted for Entos Pharmaceuticals on the deal. Entos Pharmaceuticals, Inc. and BioMarin Pharmaceutical Inc. entered into an agreement that will see Entos apply its Fusogenix nucleic...
You must be a Standard 1 Year member to access this content.
Torys represented Swift Medical on the deal. Swift Medical announced a US$35 million Series B financing. The investment round was led by Virgo Investment Group LLC...
You must be a Standard 1 Year member to access this content.
Torys LLP represented 7D Surgical on the transaction. On May 20, 2021, SeaSpine Holdings Corporation announced the closing of the previously announced acquisition of all of...
You must be a Standard 1 Year member to access this content.
Torys LLP represented 7D Surgical on the transaction. On May 20, 2021, SeaSpine Holdings Corporation announced the closing of the previously announced acquisition of all of...
You must be a Standard 1 Year member to access this content.
Torys LLP epresented AmacaThera in the offering. On February 22, 2021, AmacaThera Inc. announced that it completed an oversubscribed C$10.3 million Series A financing to support...
You must be a Standard 1 Year member to access this content.
